Coya Therapeutics, Inc. (COYA)
6.25
+0.16
(+2.63%)
USD |
NASDAQ |
Dec 11, 16:00
6.35
+0.10
(+1.60%)
After-Hours: 20:00
Coya Therapeutics EPS Diluted (Quarterly): -0.1264 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Electromed, Inc. | 0.246 |
| AbbVie, Inc. | 0.0993 |
| Atea Pharmaceuticals, Inc. | -0.5319 |
| Picard Medical, Inc. | -0.1915 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.116M |
| Revenue (Quarterly) | 3.564M |
| Total Expenses (Quarterly) | 5.680M |
| Enterprise Value | 102.65M |
| Gross Profit Margin (Quarterly) | 99.81% |
| Profit Margin (Quarterly) | -59.36% |
| Earnings Yield | -17.64% |
| Normalized Earnings Yield | -17.29 |